Evidence map›Paper›PMID 39253141›Full record

ArticleHeliyon2024

An explainable Artificial Intelligence software system for predicting diabetes.

Parvathaneni Naga Srinivasu, Shakeel Ahmed, Mahmoud Hassaballah, Naif Almusallam

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parvathaneni Naga SrinivasuDepartment of Teleinformatics Engineering, Federal University of Ceará, Fortaleza, 60455-970, Brazil.
Shakeel AhmedDepartment of Computer Science, College of Computer Sciences and Information Technology, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.
Mahmoud HassaballahDepartment of Computer Science, College of Computer Engineering and Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, 16278, Saudi Arabia.
Naif AlmusallamDepartment of Management Information Systems, College of Business Administration, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implementing diabetes surveillance systems is paramount to mitigate the risk of incurring substantial medical expenses. Currently, blood glucose is measured by minimally invasive methods, which involve extracting a small blood sample and transmitting it to a blood glucose meter. This method is deemed discomforting for individuals who are undergoing it. The present study introduces an Explainable Artificial Intelligence (XAI) system, which aims to create an intelligible machine capable of explaining expected outcomes and decision models. To this end, we analyze abnormal glucose levels by utilizing Bi-directional Long Short-Term Memory (Bi-LSTM) and Convolutional Neural Network (CNN). In this regard, the glucose levels are acquired through the glucose oxidase (GOD) strips placed over the human body. Later, the signal data is converted to the spectrogram images, classified as low glucose, average glucose, and abnormal glucose levels. The labeled spectrogram images are then used to train the individualized monitoring model. The proposed XAI model to track real-time glucose levels uses the XAI-driven architecture in its feature processing. The model's effectiveness is evaluated by analyzing the performance of the proposed model and several evolutionary metrics used in the confusion matrix. The data revealed in the study demonstrate that the proposed model effectively identifies individuals with elevated glucose levels.

Indexed as

Bi-LSTMBlood glucose levelsConvolutional neural networksHyperparametersROC curvesSpectrogram images

Identifiers

PMID39253141
PMCPMC11381601

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.